Fertility preservation; Male cancer patients; Oncofertility; Testicular tissue cryopreservation; Testicular tissue transplantation; Spermatogonial stem cells; Sperm cryopreservation; Gonadotoxicity; Assisted reproductive technologies; Oncologic safet
BACKGROUND , including chemotherapy and radiotherapy, may cause temporary or permanent impairment of spermatogenesis and endocrine testicular function. Although Advances in cancer diagnosis and treatment have increased survival rates among male patients, making the preservation of reproductive potential an important component of comprehensive oncological care. However, cancer and gonadotoxic treatmentssperm cryopreservation is an established fertility-preservation strategy for postpubertal males, options remain limited for prepubertal boys and patients unable to provide or retrieve mature sperm before treatment. AIM To review the pathophysiological mechanisms underlying cancer-associated and treatment-induced male reproductive dysfunction, examine established and emerging fertilityoncologic safety challenges of testicular tissue cryopreservation, spermatogonial stem cell transplantation, and testicular tissue transplantation.
Authors
- Ivanildo Coutinho de Medeiros (ORCID: https://orcid.org/0000-0003-3923-5360)
Institutions
- Universidade Federal do Rio Grande do Norte (BR)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24418207
- Primary Topic
- Reproductive Biology and Fertility
- Type
- article
- Field-Weighted Citation Impact
- 0.00